Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01314222 · ClinicalTrials.gov registry record · Phase 2
Diabetic Peripheral Neuropathic Pain (DPNP)
A Phase 2 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 2
- Development phase
- 178
- Enrollment target
NCT01314222: Completed Phase 2 study, sponsored by Bristol-Myers Squibb.
NCT01314222 is a Phase 2 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 178 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01314222, a Phase 2 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 178 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy of study drug (BMS-954561) as compared to placebo in the treatment of patients with diabetic peripheral neuropathic pain (DPNP).
Interventions
- DRUG Pregabalin
- DRUG BMS-954561
- DRUG Placebo matching BMS-954561
- DRUG Placebo matching Pregabalin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-07 |
| Phase | Phase 2 |
What the finished NCT01314222 record still lists
NCT01314222 is an interventional study that assigns participants to a tested intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% higher).
The record links to 0 conditions, and to 4 interventions - of which Pregabalin is the first listed.
NCT01314222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01314222 about?
NCT01314222 is a clinical study titled "Diabetic Peripheral Neuropathic Pain (DPNP)". The purpose of the study is to evaluate the efficacy of study drug (BMS-954561) as compared to placebo in the treatment of patients with diabetic peripheral neuropathic pain (DPNP).
What is the current status of trial NCT01314222?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 178 participants. The study started on 2011-03. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01314222?
The interventions under investigation include: Pregabalin (DRUG), BMS-954561 (DRUG), Placebo matching BMS-954561 (DRUG), Placebo matching Pregabalin (DRUG).
Who is sponsoring clinical trial NCT01314222?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01314222's enrollment target sits among peer trials
178 391st of 2000 higher than 1,607 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03642002 · 178 participants · NA
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
- NCT04227847 · 178 participants · Phase 1
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- NCT04855214 · 178 participants
Evaluating the Experience of Upper Limb Prosthesis Use
- NCT05391126 · 178 participants · NA
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia